Science ❯ Biomedical Research ❯ Clinical Trials ❯ Phase 3 Clinical Trials

RSV Vaccine Trials

Pfizer Seeks FDA Approval for RSV Vaccine in Young Adults

Aiming to become the first RSV vaccine for adults under 60, Pfizer's Abrysvo shows promising trial results.